ozempic tirzepatide vs Tirzepatide: Choose the Right Weight loss Treatment Ozempic, other GLP-1 weight loss

The study period began in May 2022 and concluded in April 2024, with a maximum follow-up period of one year per patient to ensure consistent comparisons between the tirzepatide and control groups

Medical Evaluation Investigate potential medical contributors to weight loss resistance: Thyroid function: Check TSH if not recently assessed, as hypothyroidism impairs weight loss Medications: Review for weight-promoting drugs (antipsychotics, certain antidepressants, corticosteroids) Sleep disorders: Screen for sleep apnea and insufficient sleep, both associated with weight loss resistance Stress and cortisol: Chronic stress elevates cortisol, promoting central adiposity and metabolic dysfunction Dose Optimization If patients have not reached the maximum tolerated dose, consider further titration according to FDA labeling

This is when you can expect gastrointestinal symptoms such as nausea, constipation, and vomiting

Some stay at the simple fatty liver stage, while others go through the stages more quickly